骨髓增殖性新生体中的避孕:药理学审查
Awni Alshurafa1, Maria Benkhadra2, Anas M Babiker1
1Hematology Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
European journal of haematology
|July 28, 2025
概括
患有骨髓增殖性瘤 (MPNs) 的女性需要仔细选择避孕药,因为凝血风险增加. 本综述指导安全选择,平衡MPN并发症与荷尔蒙和非荷尔蒙避孕方案.
科学领域:
- 血液学 血液学 血液学
- 生殖健康 生殖健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓增殖性瘤 (MPNs) 是一种慢性骨髓状组织疾病,通常是由JAK2突变驱动的.
- 多核瘤增加了血栓和出血风险,给生育年龄的女性带来了挑战.
- 荷尔蒙避孕药的相互作用和禁忌需要在MPN患者中仔细考虑.
研究的目的:
- 审查MPN妇女的避孕选择.
- 分析与各种避孕方法相关的血栓和出血风险.
- 评估MPN治疗对避孕有效性的影响.
主要方法:
- 关于MPN和避孕的综合文献综述.
- 对荷尔蒙和非荷尔蒙方法的血栓和出血风险的分析.
- 评估MPN疗法 (例如,JAK抑制剂) 和避孕药之间的药物相互作用.
主要成果:
- 含有雌激素的避孕药通常是禁用的,因为血栓形成的风险.
- 仅用孕激素和非激素的方法通常更安全,但需要个性化风险评估.
- MPN治疗可能会影响避孕疗法的有效性,需要量身定制的方法.
结论:
- 对于患有MPN的女性来说,选择避孕药需要个性化策略.
- 平衡MPN相关风险与避孕安全对于生殖健康至关重要.
- 需要进一步的研究,以优化这一群体的避孕管理.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
646
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646
Birth Control Methods
2.6K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


